CBSCCB Scientific Inc.

About CB Scientific Inc. (CBSC)

CB Scientific Inc. (CBSC) is a Medical Instruments & Supplies company headquartered in Las Vegas, NV, United States whose shares trade over-the-counter on the Pink tier.

CB Scientific, Inc., through its international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians. CB Scientific's wholly owned U.S. subsidiary, My-Cardia (USA), Inc., develops ECG recording device worn by patients in an ambulatory setting for up to 30 days. Our monitors can record both patient-activated ECGs, as well as asymptomatic events by the on-board analysis algorithm in certain models. Recorded ECGs are easy to transmit acoustically over a phone. ECG reports can be reviewed and/or printed using our cloud-based software which can be accessed from computers, tablets, or smartphones. CB Scientific Inc. has authorized distributors in Thailand, Singapore, Malaysia, Indonesia, Hong Kong, Macau, and Canada.

Products and services

On June 22, 2020, the Company completed an acquisition of the assets of Prevent Health Care International Corporation (“PHCIC”), a private British Columbia, Canada corporation involved in the development, sale and service of an innovative arrhythmia diagnostic and heart-monitoring intellectual property, and related products. The primary assets of PHCIC are its wholly-owned subsidiaries: MyCardia (USA) Inc., incorporated in California, MyCardia (HK) Ltd., incorporated in Hong Kong, China, and Shenzhen Maikadi Medical Technology, Ltd. incorporated in China. MyCardia (USA) Inc. is a fully operating company whereas MyCardia (HK) Ltd. and Shenzhen Maikadi Medical Technology, Ltd. do not yet have operations. The acquired products and services are available in the U.S. and through PHCIC’s international subsidiaries using proprietary FDA and CE-cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms. The combination of devices and software provides improved compliance for patients at risk of abnormal heart rhythms, as well as more accurate information for physicians.

CBSC key facts

Ticker symbol

CBSC

Market tier

Pink

Sector

Healthcare

Industry

Medical Instruments & Supplies

Headquarters

Las Vegas, NV, United States

Country of incorporation

US

Year of incorporation

2022

Employees

4

Estimated market cap

$5.77M (as of Apr 10, 2025)

Shares outstanding

162,173,702

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

3/31

Latest filing

Quarterly Report (Dec 31, 2024)

CB Scientific Inc. leadership

• Charles K Martin — President, CEO
• William (Trip) Griffin Thomas — CFO
• James E. Ott — CTO

Explore more: Medical Instruments & Supplies stocks · Healthcare sector · Pink stocks · OTC stocks starting with C